期刊
ATHEROSCLEROSIS
卷 221, 期 2, 页码 366-374出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2011.12.034
关键词
Aortic valve stenosis; Lymphangiogenesis; Mast cells; Myofibroblasts; Vascular endothelial growth factor C
资金
- Finnish Foundation for Cardiovascular Research, Helsinki, Finland
- Finnish Medical Foundation
- EVO of Helsinki University Central Hospital
Objective: To investigate mechanisms of lymphangiogenesis in aortic valve stenosis (AS). Methods: Lymphatic vessels were visualized with LYVE-1 staining in 20 control, 5 sclerotic, and 40 stenotic human aortic valves. Vascular endothelial growth factors (VEGFs) VEGF-C and VEGF-D, and their lymphangiogenic receptor VEGFR-3, and the angiogenic VEGFR-2 were analysed by quantitative real-time PCR and immunohistochemistry. Cultured myofibroblasts derived from human stenotic aortic valves, and cultured human mast cells were used to study VEGF-C regulation, and VEGF-C and VEGF-A were quantified from cell culture media by enzyme immunoassays. Results: Lymphatic vessels, VEGF-C, VEGF-D, VEGFR-3 and VEGFR-2 all were present in the aortic valves. In AS, the number of lymphatic vessels and the expression of VEGF-D, VEGFR-3, and VEGFR-2 were increased. Moreover, the numbers of lymphatic vessels correlated positively with those of neovessels (r = 0.525, p = 0.001) and mast cells (r = 0.374, p = 0.017). Cultured valvular myofibroblasts produced VEGF-C, and addition of tumour necrosis factor alpha (TNF-alpha) to the cells augmented its secretion. In contrast, proteases released by activated human mast cells degraded VEGF-C. Conclusion: These results show that lymphangiogenesis is induced in advancing AS. Furthermore, valvular myofibroblasts and activated mast cells were identified as novel regulators of lymphangiogenesis in aortic valves. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据